“…Twenty-three contributed to the narrative summary and are cited in the paper. These included 2 RCTs [36,37], 13 nonrandomized comparative studies [6,8,[38][39][40][41][42][43][44][45][46][47][48], and 7 single group studies [49][50][51][52][53][54][55], and the remaining articles [5,7,39,41,43,46,50,53, included consensus documents, cost-effectiveness analyses, and narrative reviews. Of note, most of our literature review and review of expert opinion was in line with the International Guidelines from the Infectious Disease Society of America (IDSA) and European Society for Microbiology and Infectious Disease (ESMID) recommendations, including choice of antibiotic for first-line therapy [84].…”